Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ALDEYRA THERAPEUTICS, INC. (ALDX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ALDEYRA THERAPEUTICS, INC. (ALDX), most recent 12 months reported: net loss $23.05M. Latest balance sheet on file: liquid cash $45.09M. From SEC filings. Others in Pharmaceutical Preparations: Acurx Pharmaceuticals, Inc. · ADIAL PHARMACEUTICALS, INC. · AEON Biopharma, Inc. · Akari Therapeutics, Plc · ALX ONCOLOGY HOLDINGS INC · ALZAMEND NEURO, INC. · Amylyx Pharmaceuticals, Inc. · ANEBULO PHARMACEUTICALS, INC.

Stock screener

Watchlist